<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00527007</url>
  </required_header>
  <id_info>
    <org_study_id>SCR06012</org_study_id>
    <nct_id>NCT00527007</nct_id>
  </id_info>
  <brief_title>External Cooling in Septic Shock Patients</brief_title>
  <acronym>sepsis-cool</acronym>
  <official_title>Impact of External Cooling in Septic Shock Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rapidity of the resolution of cardiovascular failure has a strong impact on septic shock
      patients' outcome. The aim of this multicenter randomized controlled trial is to determine
      whether external cooling might accelerate improvement in cardiovascular function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients suffering from septic shock need fluid resuscitation and vasopressor therapy for
      restoring cardiovascular function. Corticosteroids and activated protein C have been both
      proposed for vascular tone improvement. While external cooling is largely used in ICU febrile
      patients, benefits and risks of fever treatment during sepsis have been rarely studied.
      Surveys show that external cooling is usual care applied by nurses themselves without medical
      order.

      The control of thermal balance might decrease cardiac output and oxygen consumption, and
      reduce serum lactate concentration. However some animal studies have suggested that fever
      might be essential for host defence. This trial compares two strategies of fever management
      on vasopressor dependence in septic shock patients. In the treatment group, external cooling
      is applied to normalize the body temperature between 36°5 C and 37°C, while control patients
      receive any fever treatment. The goal for mean arterial pressure is the same in the two
      groups and vasopressor withdrawal is determined by similar algorithm.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with a decrease in the dose of vasopressors of 50% 48 hours after enrolment</measure>
    <time_frame>48 hours after enrolment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal dose of vasopressors</measure>
    <time_frame>within 48 hours after enrolment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score evolution</measure>
    <time_frame>on Day 3, Day 7, Day 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of vasopressor free days in the ICU</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>External cooling</intervention_name>
    <description>External cooling</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented or suspected infection

          -  Body temperature &gt; 38.3°C

          -  Persistent hypotension despite fluid resuscitation and need for vasopressor infusion
             to maintain mean arterial pressure &gt; 65 mmHg.

          -  Invasive mechanical ventilation

          -  Intravenous sedation

        Exclusion Criteria:

          -  Temperature &gt; 41°C

          -  Age &lt; 18 years

          -  Pregnancy

          -  Continuous renal replacement therapy

          -  Paracetamol or NSAI administration within 6 hours before inclusion

          -  Need for paracetamol and/or NSAI therapy during the study period

          -  Burns or Lyell syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederique SCHORTGEN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2007</study_first_submitted>
  <study_first_submitted_qc>September 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2007</study_first_posted>
  <last_update_submitted>July 21, 2010</last_update_submitted>
  <last_update_submitted_qc>July 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Saliha DJANE</name_title>
    <organization>Department of Clinical Research of Development</organization>
  </responsible_party>
  <keyword>Vasopressor</keyword>
  <keyword>Epinephrine</keyword>
  <keyword>Norepinephrine</keyword>
  <keyword>Cooling</keyword>
  <keyword>Fever</keyword>
  <keyword>ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

